Engineered Nanoparticles for Drug Delivery in Cancer Therapy
The DOI matches its Crossref record; 579 of the 579 references it cites were found in a registry or an index.
Abstract
In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a number of issues associated with conventional therapeutic agents, including their poor water solubility (at least, for most anticancer drugs), lack of targeting capability, nonspecific distribution, systemic toxicity, and low therapeutic index. Over the past several decades, remarkable progress has been made in the development and application of engineered nanoparticles to treat cancer more effectively. For example, therapeutic agents have been integrated with nanoparticles engineered with optimal sizes, shapes, and surface properties to increase their solubility, prolong their circulation half‐life, improve their biodistribution, and reduce their immunogenicity. Nanoparticles and their payloads have also been favorably delivered into tumors by taking advantage of the pathophysiological conditions, such as the enhanced permeability and retention effect, and the spatial variations in the pH value. Additionally, targeting ligands (e.g., small organic molecules, peptides, antibodies, and nucleic acids) have been added to the surface of nanoparticles to specifically target cancerous cells through selective binding to the receptors overexpressed on their surface. Furthermore, it has been demonstrated that multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be delivered through the same carrier to enable combination therapy with a potential to overcome multidrug resistance, and real‐time readout on the treatment efficacy. It is anticipated that precisely engineered nanoparticles will emerge as the next‐generation platform for cancer therapy and many other biomedical applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Vasculature plays an essential role in the growth and metastasis of malignant tumors [103].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
Citations
Cites
Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Chemistry and Properties of Nanocrystals of Different Shapes
Burda, C., Chen, X., Narayanan, R., & El-Sayed, M. A. (2005) · Chemical Reviews · doi:10.1021/cr030063a · Cited by 7,230
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Research works printed but not linked: 29
- Aruna U., 2013, Inter. J. Inn. Pharm. Res., 4, 318
- Langer R., 1998, Nature, 392, 5
- Petre C. E., 2007, Int. J. Nanomed., 2, 277
- Lao J., 2013, J. Drug Delivery, 456409
- Saif M. W., 2007, JOP, 8, 166
- Matsumura Y., 1986, Cancer Res., 46, 6387
- Xu G., 2001, Clin. Cancer Res., 7, 3314
- 10.1016/j.addr.2012.09.008 · doi:10.1016/j.addr.2012.09.008 · Paper page
- Pundir S., 2013, Int. J. Drug Res. Technol., 3, 12
- 10.1021/jp077468 · doi:10.1021/jp077468
- Mohanraj V. J., 2006, J. Pharm. Res., 5, 561
- Ma Y. D., 2011, Int. J. Nanomed., 6, 2679
- 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F · doi:10.1002/(sici)1097-4636(199908)46:2<236::aid-jbm13>3.0.co;2-f
- Krishna R., 2000, Eur. J. Cancer Sci., 11, 265
- Kettiger H., 2013, Int. J. Nanomed., 8, 3255
- Yuan F., 1995, Cancer Res., 55, 3752
- Jain R. K., 1987, Cancer Res., 47, 3039
- 10.1021/nn900002m · DOI · Paper page
- Chidambaram M., 2012, Int. J. Pharm. Sci., 2, 117
- 10.1039/C1CS15237H · DOI · Paper page
- 10.1038/nnano.2007.223 · DOI · Paper page
- Mohanraj V. J., 2006, Trop. J. Pharm. Res., 5, 561
- Hong R. L., 1999, Clin. Cancer Res., 5, 3645
- Shamsipour F., 2009, Avicenna J. Med. Biotechnol., 1, 27
- Park J. W., 2002, Clin. Cancer Res., 8, 1172
- Uppada S. B., 2014, Int. J. Nanomed., 9, 43
- Bangham A. D., 1965, J. Mol. Biol., 13, 227
- Mueller C., 1994, Methods Cell Sci., 16, 183
- 10.1016/j.cbpa.2005.10.005 · DOI
Cited by
Items 501–600 of 1,005
Zhu, Y. M., Cao, W., Han, C., Wang, Z., Qiu, Y., Wang, J., Wei, M., Wang, J., Zhang, S., Liu, S., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.796820 · Cited by 66
Shiny, P. J., Mukherjee, A., & Chandrasekaran, N. (2016) · RSC Advances · doi:10.1039/c5ra27185a · Cited by 62
Smart multifunctional nanoparticles in nanomedicine
Şeleci, M., Seleci, D. A., Joncyzk, R., Stahl, F., Blume, C. A., & Scheper, T. H. (2016) · BioNanoMaterials · doi:10.1515/bnm-2015-0030 · Cited by 72
“Monoclonal antibodies (mAbs) are widely preferred targeting ligands because of their availability to research and their high affinity and specificity for molecular targets [49, 50].”
BackgroundDangi, A. K., Sharma, B., Khangwal, I., & Shukla, P. (2018) · Molecular Biotechnology · doi:10.1007/s12033-018-0100-9 · Cited by 65
Nikam, A. N., Pandey, A. P., Fernandes, G. J., Kulkarni, S., Mutalik, S. P., Padya, B. S., George, S. D., & Mutalik, S. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213356 · Cited by 64
Cancer-Nano-Interaction: From Cellular Uptake to Mechanobiological Responses
Kashani, A. S., & Packirisamy, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179587 · Cited by 66
“Bio-distribution, biocompatibility, biodegradability, and systemic clearance are the general challenges of using NPs in the targeted therapy [14].”
BackgroundTutty, M. A., Movia, D., & Prina‐Mello, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01147-0 · Cited by 75
“The liver is a key organ of interest for NBM toxicity responses, for a variety of different reasons [26, 27].”
BackgroundRational design of ICD-inducing nanoparticles for cancer immunotherapy
Zhang, Z., Pan, Z., Li, Q., Huang, Q., Shi, L., & Liu, Y. (2024) · Science Advances · doi:10.1126/sciadv.adk0716 · Cited by 72
Review peptide‐targeted liposomes for selective drug delivery: Advantages and problematic issues
Accardo, A., & Morelli, G. (2015) · Biopolymers · doi:10.1002/bip.22678 · Cited by 62
Rossi, L., Pierigè, F., Antonelli, A., Bigini, N., Gabucci, C., Peiretti, E., & Magnani, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.008 · Cited by 63
Wang, Y., Liu, W., & Yin, X. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201602925 · Cited by 61
Tran, V. A., & Lee, S. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.09.072 · Cited by 62
Ding, H., & Ma, Y. (2017) · Nanoscale Horizons · doi:10.1039/c7nh00138j · Cited by 63
Schwaminger, S. P., Blank-Shim, S. A., Scheifele, I., Pipich, V., Fraga‐García, P., & Berensmeier, S. (2018) · Biotechnology Journal · doi:10.1002/biot.201800055 · Cited by 66
Mannose‐Functionalized Nanoscaffolds for Targeted Delivery in Biomedical Applications
Jing Hua, H. U., Wei, P., Seeberger, P. H., & Yin, J. (2018) · Chemistry - An Asian Journal · doi:10.1002/asia.201801088 · Cited by 61
Yin, X., Yang, B., Chen, B., He, M., & Hu, B. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b01721 · Cited by 61
Nano-Elicitation of Secondary Pharmaceutical Metabolites in Plant Cells: A Review
Hatami, M., Badi, H. N., & Ghorbanpour, M. (2019) · Journal of Medicinal Plants · doi:10.29252/jmp.3.71.6 · Cited by 76
Multichannel Stimulus-Responsive Nanoprobes for H2O2 Sensing in Diverse Biological Milieus
Zhang, C., Liu, X., Xu, Z., & Liu, D. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02769 · Cited by 61
Cancer treatment and toxicity outlook of nanoparticles
Neetika, N., Sharma, M., Thakur, P., Gaur, P., Rani, G. M., Rustagi, S., Talreja, R. K., & Chaudhary, V. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116870 · Cited by 61
Pramanik, A., SiddikUzzaman, B. S. P., Palanimuthu, D., Somasundaram, K., & Samuelson, A. G. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00537 · Cited by 65
Novel agents for sperm purification, sorting, and imaging
Feugang, J. M. (2017) · Molecular Reproduction and Development · doi:10.1002/mrd.22831 · Cited by 64
An Integrated Therapeutic Delivery System for Enhanced Treatment of Hepatocellular Carcinoma
Zhou, Y., Wu, W., Qin, Y., Jing Hua, H. U., Liu, C., Seeberger, P. H., & Yin, J. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201706600 · Cited by 62
Chen, X., Tieleman, D. P., & Liang, Q. D. (2018) · Nanoscale · doi:10.1039/c7nr06494b · Cited by 60
Levchenko, I., Bazaka, K., Baranov, O., Sankaran, R. M., Nominé, A., Belmonte, T., & Xu, S. (2018) · Applied Physics Reviews · doi:10.1063/1.5024865 · Cited by 61
Photothermal effect by NIR-responsive excretable ultrasmall-in-nano architectures
Cassano, D., Santi, M., D’Autilia, F., Mapanao, A. K., Luin, S., & Voliani, V. (2019) · Materials Horizons · doi:10.1039/c9mh00096h · Cited by 61
Zheng, K., Liu, X., Liu, H., Dong, D., Li, L., Jiang, L., Huang, M., & Ding, C. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c19027 · Cited by 59
Elle, R. E., Rahmani, S., Lauret, C., Morena-Carrere, M., Bidel, L., Boulahtouf, A., Balaguer, P., Cristol, J., Durand, J., Charnay, C., et al. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00190 · Cited by 61
Zhang, Y., Guo, Q., An, S., Lü, Y., Li, J., He, X., Liu, L., Zhang, Y., Sun, T., & Jiang, C. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b16815 · Cited by 59
Self-citationProtein Adsorption to Charged Gold Nanospheres as a Function of Protein Deformability
Dennison, J. M., Zupancic, J. M., Lin, W., Dwyer, J. H., & Murphy, C. J. (2017) · Langmuir · doi:10.1021/acs.langmuir.7b01909 · Cited by 71
Zhou, J., Li, M., Lim, W. Q., Luo, Z. Y., Phua, S. Z. F., Huo, R., Li, L., Li, K., Dai, L., Liu, J., et al. (2017) · Theranostics · doi:10.7150/thno.21194 · Cited by 59
“The advent of nanotechnology has greatly impacted various aspects of anticancer research, as it offers innovative and unprecedented technological solutions to difficult clinical problems in oncology.[1-5] Remarkably, one area of particular interest in nano-oncology is the development of nanoparticle-based drug reservo…”
BackgroundNear Infrared Boron Dipyrromethene Nanoparticles for Optotheranostics
Huang, L. F., & Han, G. (2018) · Small Methods · doi:10.1002/smtd.201700370 · Cited by 59
Wang, S., Li, B., Zhang, H., Chen, J., Sun, X., Xu, J. H., Ren, T., Zhang, Y., Ma, C., Guo, W., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202101938 · Cited by 60
Self-citationFrieler, M., Pho, C., Lee, B. H., Dobrovolny, H. M., Akkaraju, G. R., & Naumov, A. V. (2021) · Nanomaterials · doi:10.3390/nano11010140 · Cited by 59
“Such approaches are novel because they optimize the properties of the nanomaterial that have been often limited by clinical data and nanotherapeutics for clinical use [50], allowing for one to increase efficacy and/or repurpose existing therapeutics [51].”
BackgroundNanotechnology as a tool to overcome macromolecules delivery issues
Tundisi, L. L., Ataide, J. A., Costa, J. S. R., Coêlho, D. D. F., Liszbinski, R. B., Lopes, A. M., Nascimento, L. D. O., de Jesus, M. B., Jozala, Â. F., Ehrhardt, C., et al. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.113043 · Cited by 64
Ramya, A. N., Joseph, M. M., Maniganda, S., Karunakaran, V., Sreelekha, T. T., & Maiti, K. K. (2017) · Small · doi:10.1002/smll.201700819 · Cited by 59
An Intravascular Magnetic Catheter Enables the Retrieval of Nanoagents from the Bloodstream
Iacovacci, V., Ricotti, L., Sinibaldi, E., Signore, G., Vistoli, F., & Menciassi, A. (2018) · Advanced Science · doi:10.1002/advs.201800807 · Cited by 60
Alhajj, N., Zakaria, Z., Naharudin, I., Ahsan, F., Li, W., & Wong, T. W. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.02.001 · Cited by 59
Therapeutic Nanoparticles for Targeted Delivery of Anticancer Drugs
Alasvand, N., Urbanska, A. M., Rahmati, M., Saeidifar, M., Gungor‐Ozkerim, P. S., Sefat, F., Rajadas, J., & Mozafari, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52725-5.00013-7 · Cited by 83
Chen, Z., Li, S., Li, F., Qin, C., Li, X., Qing, G., Wang, J., Xia, B., Zhang, F., Meng, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202206707 · Cited by 62
Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function
Uzhytchak, M., Smolková, B., Lunová, M., Frtús, A., Jirsa, M., Dejneka, A., & Lunov, O. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114828 · Cited by 65
Magnetic Particle Imaging: From Tracer Design to Biomedical Applications in Vasculature Abnormality
Xie, X., Zhai, J., Zhou, X., Guo, Z., Lo, P., Zhu, G., Chan, K. W. Y., & Yang, M. (2023) · Advanced Materials · doi:10.1002/adma.202306450 · Cited by 62
Self-citationNanotechnology in oncology: advances in biosynthesis, drug delivery, and theranostics
Ammar, M. M., Ali, R., Elaziz, N. A. A., Habib, H., Abbas, F. M., Yassin, M. T., Maniah, K., & Abdelaziz, R. (2025) · Discover Oncology · doi:10.1007/s12672-025-02664-3 · Cited by 73
The potential of nanoparticles for the immunization against viral infections
Sokolova, V., Westendorf, A. M., Buer, J., Überla, K., & Epple, M. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00618j · Cited by 66
Nanoparticles for immune system targeting
Du, J., Zhang, Y. S., Hobson, D., & Hydbring, P. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.03.013 · Cited by 57
Self-citationEngineering and delivery of nanocolloids of hydrophobic drugs
Zhao, L., Shen, G., Ma, G., & Yan, X. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.04.008 · Cited by 60
MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells
Hanafi‐Bojd, M. Y., Moosavian, S. A., Taghdisi, S. M., Ansari, L., Abnous, K., & Malaekeh‐Nikouei, B. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1371734 · Cited by 57
“Moreover, chemotherapy creates adverse effects on the healthy tissues [1,2].”
BackgroundJiang, W., Mo, F., Lin, Y., Wang, X., Xu, L., & Fu, F. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00670a · Cited by 57
Cell Membrane–Camouflaged Colloid Motors for Biomedical Applications
Gao, C., Lin, Z., Lin, X., & He, Q. Z. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800056 · Cited by 57
Avila-Arias, H., Nies, L. F., Bischoff, M., & Turco, R. F. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.10.189 · Cited by 58
Li, Y., Lu, H., Liang, S., & Xu, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b03960 · Cited by 59
Wang, T., Guo, Y., He, Y., Ren, T., Yin, L., Fawcett, J. P., Gu, J., & Huimin, S. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.001 · Cited by 67
Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis
Mignani, S. M., Shi, X., Rodrigues, J., Roy, R., Muñoz‐Fernández, M. Á., Ceña, V., & Majoral, J. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00395 · Cited by 61
Wang, Y., Zu, M., Ma, X., Jia, D., Lu, Y., Zhang, T., Xue, P., Kang, Y., & Xu, Z. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c15781 · Cited by 56
Wang, Z., Yan, Y., Li, C., Yu, Y., Cheng, S., Chen, S., Zhu, X., Sun, L., Tao, W., Liu, J., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c00327 · Cited by 57
Sandhöfer, B., Meckel, M., Delgado‐López, J. M., Patrício, T., Tampieri, A., Rösch, F., & Iafisco, M. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b02624 · Cited by 59
Wu, X., Zhou, L., Su, Y., & Dong, C. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b00721 · Cited by 57
Nanosized inorganic porous materials: fabrication, modification and application
Zheng, H., Gao, F., & Valtchev, V. (2016) · Journal of Materials Chemistry A · doi:10.1039/c6ta04684c · Cited by 59
Jia, Q., Ge, J., Liu, W., Guo, L., Zheng, X., Chen, S., Chen, M., Liu, S., Zhang, L., Wang, M., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601419 · Cited by 58
Das, R. P., Singh, B. G., Kunwar, A., Ramani, M. V., Subbaraju, G. V., Hassan, P. A., & Priyadarsini, K. I. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.07.048 · Cited by 57
Wang, D., Zhu, L. H., Pu, Y., Wang, J., Chen, J., & Dai, L. (2017) · Nanoscale · doi:10.1039/c7nr03019c · Cited by 57
Jiang, W., Mo, F., Jin, X., Chen, L., Xu, L., Guo, L., & Fu, F. (2017) · Advanced Materials Interfaces · doi:10.1002/admi.201700425 · Cited by 56
Gupta, B., Poudel, B. K., Ruttala, H. B., Regmi, S., Pathak, S., Gautam, M., Jin, S. G., Jeong, J., Choi, H., Ku, S., et al. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.09.006 · Cited by 56
Gold-based Inorganic Nanohybrids for Nanomedicine Applications
Ding, X., Li, D., & Jiang, J. (2020) · Theranostics · doi:10.7150/thno.42284 · Cited by 58
“The development of facile synthesis and surface functionalization strategies of Au NPs have pushed forward their practical applications in the field of nanobiomedicine, including bioimaging [37-41], drug delivery [42-44], cancer diagnosis, and therapeutics [45-50].”
BackgroundPotara, M., Bawaskar, M., Nagy-Simon, T., Gaikwad, S. C., Licărete, E., Ingle, A. P., Banciu, M., Vulpoi, A., Aştilean, S., & Rai, M. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.06.024 · Cited by 56
Biodegradable hollow silica nanospheres containing gold nanoparticle arrays
Cassano, D., Martir, D. R., Signore, G., Piazza, V., & Voliani, V. (2015) · Chemical Communications · doi:10.1039/c5cc02771c · Cited by 55
Polydopamine Nanosystems in Drug Delivery: Effect of Size, Morphology, and Surface Charge
Menichetti, A., Mordini, D., & Montalti, M. (2024) · Nanomaterials · doi:10.3390/nano14030303 · Cited by 60
“These properties overcome the issue of non-specificity, which is one of the biggest issues for drug delivery, especially in anticancer therapy that aims to eliminate toxic agents in normal cells [10,11].”
BackgroundNanoparticles Functionalized with Supramolecular Host–Guest Systems for Nanomedicine and Healthcare
Wu, Z., Song, N., Menz, R., Pingali, B., Yang, Y., & Zheng, Y. (2015) · Nanomedicine · doi:10.2217/nnm.15.1 · Cited by 56
Chen, W., Luo, G., Qiu, W., Lei, Q., Hong, S., Wang, S., Zheng, D., Zhu, C., Zeng, X., Feng, J. X., et al. (2015) · Small · doi:10.1002/smll.201503280 · Cited by 57
Tunable self-assembly of Irinotecan-fatty acid prodrugs with increased cytotoxicity to cancer cells
Zhang, C., Jin, S., Xue, X., Zhang, T., Jiang, Y., Wang, P. C., & Liang, X. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00612d · Cited by 55
Yao, C., Tian, J., Wang, H., Zhang, D., Liu, Y., Zhang, F., & Li, Z. (2017) · Chinese Chemical Letters · doi:10.1016/j.cclet.2017.01.005 · Cited by 55
Huang, W., Tsui, C. P., Tang, C. Y., Yang, M., & Gu, L. (2017) · Composites Part B Engineering · doi:10.1016/j.compositesb.2017.03.028 · Cited by 58
Self-citationThermo- and pH-responsive nano-in-micro particles for combinatorial drug delivery to cancer cells
Moreira, A. F., Dias, D. R., Costa, E. C., & Correia, I. J. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.03.033 · Cited by 56
Bioresponsive functional nanogels as an emerging platform for cancer therapy
Huang, D., Qian, H., Qiao, H., Chen, W., Feijén, J., & Zhong, Z. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1497607 · Cited by 55
Rybka, J. D. (2019) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2019.01.002 · Cited by 59
Jiang, Y., Yu, X., Su, C., Zhao, L., & Shi, Y. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1577876 · Cited by 58
Breakthroughs in medicine and bioimaging with up-conversion nanoparticles
Rostami, I., Alanagh, H. R., Hu, Z., & Shahmoradian, S. H. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s221433 · Cited by 59
“10 Also, drugs with a higher effectiveness can possess a higher toxic pro fi le that may lead to adverse effects and most notably cause damage to normal and healthy sites.”
Photosensitive nanocarriers for specific delivery of cargo into cells
Mena‐Giraldo, P., Pérez-Buitrago, S., Londoño-Berrío, M., Ortiz-Trujillo, I. C., Palacio, L. M. H., & Orozco, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-58865-z · Cited by 55
Emerging nanobiomaterials against bacterial infections in postantibiotic era
Hu, D., Zou, L., Gao, Y., Jin, Q., & Ji, J. (2020) · View · doi:10.1002/viw.20200014 · Cited by 57
An, L., Zhang, P., Shen, W. H., Yi, X., Yin, W.-T., Jiang, R., & Xiao, C. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.10.027 · Cited by 60
Killing cancer cells by rupturing their lysosomes
Qiu, J., & Younan Xia, A. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0639-z · Cited by 55
Applications of co-axial electrospinning in the biomedical field
Khan, J., Khan, A., Khan, M. Q., & Khan, H. (2024) · Next Materials · doi:10.1016/j.nxmate.2024.100138 · Cited by 67
Dinuclear Tridentate Ru(II) Complex with Strong Near-Infrared Light-Triggered Anticancer Activity
Li, W., Kushwaha, R., Sadhukhan, T., Wu, H., Dao, A., Zhang, Z., Zhu, H., Gong, Q., Ru, J., Liang, C., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00624 · Cited by 56
Self-assembled NIR nanovesicles for long-term photoacoustic imaging in vivo
An, H., Qiao, S., Hou, C., Lin, Y., Li, L., Xie, H.-Y., Wang, Y., Wang, L., & Wang, H. (2015) · Chemical Communications · doi:10.1039/c5cc05395a · Cited by 54
Regulation of Interparticle Forces Reveals Controlled Aggregation in Charged Nanoparticles
Rao, A., Roy, S., Unnikrishnan, M., Bhosale, S. S., Devatha, G., & Pillai, P. P. (2016) · Chemistry of Materials · doi:10.1021/acs.chemmater.6b00493 · Cited by 56
Rehman, M., Madni, A., Shi, D., Ihsan, A., Tahir, N., Chang, K. R., Javed, I., & Webster, T. J. (2017) · Nanoscale · doi:10.1039/c7nr05216b · Cited by 54
Jensen, A. I., Severin, G. W., Hansen, A. E., Fliedner, F. P., Eliasen, R., Parhamifar, L., Kjær, A., Andresen, T. L., & Henriksen, J. R. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.006 · Cited by 55
Molecular-scale drug delivery systems loaded with oxaliplatin for supramolecular chemotherapy
Yang, J., Dai, D., Ma, L., & Yang, Y. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.08.035 · Cited by 54
Boosting Clinical Translation Of Nanomedicine
Jang, H. L., Zhang, Y. S., & Khademhosseini, A. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0133 · Cited by 57
Self-citationAdvances in Nanodelivery of Green Tea Catechins to Enhance the Anticancer Activity
Jiang, Y., Jiang, Z., Ma, L., & Huang, Q. (2021) · Molecules · doi:10.3390/molecules26113301 · Cited by 56
Kapri, S., Maiti, S., & Bhattacharyya, S. (2016) · Carbon · doi:10.1016/j.carbon.2016.01.017 · Cited by 53
Cu(II) doped polyaniline nanoshuttles for multimodal tumor diagnosis and therapy
Lin, M., Wang, D., Li, S., Tang, Q., Liu, S., Ge, R., Liu, Y., Zhang, D., Sun, H., Zhang, H., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.021 · Cited by 53
Fang, T., Dong, Y., Zhang, X., Xie, K., Lin, L., & Wang, H. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.08.036 · Cited by 53
pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin
Yang, S., Tang, Z., Zhang, D., Deng, M., & Chen, X. (2017) · Biomaterials Science · doi:10.1039/c7bm00632b · Cited by 55
Nanomedicine tactics in cancer treatment: Challenge and hope
Zoubi, M. S. A., & Al‐Zoubi, R. M. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103677 · Cited by 54
Han, X., Shen, J., Chen, S., Cai, Z., Zhu, Y., Yi, W., Li, K., Cai, W., Tao, B., Cui, W., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122057 · Cited by 55
Kumar, P., Lakshmi, Y. S., & Kondapi, A. K. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2048-4 · Cited by 52
Maley, A. M., Lu, G. J., Shapiro, M. G., & Corn, R. M. (2017) · ACS Nano · doi:10.1021/acsnano.7b03859 · Cited by 55
Cancer Nanomedicine: Lessons for Immuno-Oncology
Sengupta, S. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.06.006 · Cited by 54
Andreozzi, P., Diamanti, E., Py-Daniel, K. R., Cáceres‐Vélez, P. R., Martinelli, C., Πολιτάκος, Ν., Escobar, A., Muzi-Falconi, M., Azevedo, R. B., & Moya, S. E. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b11132 · Cited by 56
Duan, Z., Cai, H., Zhang, H., Chen, K., Li, N., Xu, Z., Gong, Q., & Luo, K. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b12232 · Cited by 56
Metadata
- Authors
- Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y.
- Affiliations
- Georgia Institute of Technology (US)
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2014-10-07
- Volume
- 53
- Issue
- 46
- Pages
- 12320-12364
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2134726513
- Cited by
- 2,164
- References
- 578
- Citations by year
- 2026: 57 · 2025: 146 · 2024: 163 · 2023: 153 · 2022: 209 · 2021: 200 · 2020: 221 · 2019: 237 · 2018: 257 · 2017: 230 · 2016: 180 · 2015: 109 · 2014: 2
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Angewandte Chemie International Edition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- engineered nanoparticles, drug delivery, cancer therapy, targeted drug delivery, enhanced permeability and retention effect, pH-responsive delivery, tumor-targeting ligands, tissue distribution, circulation half-life, immunogenicity, combination therapy, multidrug resistance, contrast media, theranostics, nanoparticle surface modification
- MeSH terms
- Animals, Antineoplastic Agents, Delayed-Action Preparations, Humans, Neoplasms, Drug Delivery Systems, Nanotechnology, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.